Hypoxia induced abnormal activation of hypoxia-inducible factor-1α (HIF-1α) in the immune microenvironment, and also upregulated LDHA and GLUT1 to cause glycolysis, which promoted the progression of HCC and led to enhanced drug resistance of cancer cells (Zhou et al., 2022). The gene discussed is HIF1A; the disease is cancer.